News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

Generative AI Is Upending Freelance Work – Even Top Performers Aren’t Safe
News Release

BALTIMORE, MD, March 4, 2025 – A groundbreaking study has uncovered a startling reality: generative AI tools like ChatGPT are already reshaping the freelance job market, slashing employment opportunities and pay for workers across all skill levels. Even top freelancers – those with the strongest track records – are suffering the greatest setbacks.

Read More
The 3 biggest things to know about a potential U.S.-Ukraine minerals deal
Media Coverage

Contentious minerals deal has sparked a war of words between Trump and Zelensky, and could be announced later this week

Read More
How tariffs can hurt American supply chains | GUEST COMMENTARY
Media Coverage

Americans have probably heard the word “tariffs” more in the past month than in the past four years — and for good reason. Tariffs are central to President Donald Trump’s economic playbook, despite opposition from mainstream economists and trade experts

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
Vaccine Waste at 0.1% Fails to Ease the Worries of U.S. Doctors

Vaccine Waste at 0.1% Fails to Ease the Worries of U.S. Doctors

Bloomberg, April 22, 2021

States across the U.S. are reporting little waste of Covid-19 vaccine, in what appears to be evidence that careful handling of doses amid soaring demand is helping get almost every available shot into the arms of Americans.

Watch: A Stress Test for Supply Chains, Part 2

Watch: A Stress Test for Supply Chains, Part 2

Supply Chain Brain, April 19, 2021

David Simchi-Levi, professor of engineering systems at MIT, brings us up to date on the results of applying a supply-chain “stress test” to companies in multiple industries.

Johnson & Johnson COVID Vaccine Maker Emergent BioSolutions Asked To Stop Making Doses While FDA Investigation Underway

Johnson & Johnson COVID Vaccine Maker Emergent BioSolutions Asked To Stop Making Doses While FDA Investigation Underway

WJZ-TV 13, April 19, 2021

BALTIMORE (WJZ) — Emergent BioSolutions, the Baltimore, Maryland-based company manufacturing the Johnson & Johnson coronavirus vaccines, was asked to stop manufacturing COVID-19 related products, while the Food & Drug Administration continues its investigation into quality control issues at the plant that ruined 15 million potential doses of the vaccine.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine